Clinical Trial Update: A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase II, open-label, single-arm multicenter trial of chlorambucil in Japanese patients with previously untreated chronic lymphocytic leukemia; results from the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Chlorambucil (chlorambucil)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Leukaemia, Lymphoblastic | Phase 2 | Status: COMPLETED | Results posted: 2015-06-22